VIDO-InterVac is a global leader in human and animal infectious disease research and vaccine development. We conduct research from discovery through to preclinical (human) and full-clinical trials (animal).
Current research targets a wide range of viral, bacterial and prion diseases, and the development of innovative of platform technologies.
Our research is organized into the following programs:
- Bacterial Vaccine Development
- Viral Vaccine Development
- Vaccine Formulation and Delivery
- Clinical Research and Animal Care